COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04534322
Brief Title: Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma (sEAPort)

First Submitted : August 26, 2020
First Submitted that Met QC Criteria : August 26, 2020
First Posted : September 1, 2020

Last Update Submitted that Met QC Criteria : November 19, 2020
Last Update Posted : November 23, 2020